1. Home
  2. EVAX vs GTI Comparison

EVAX vs GTI Comparison

Compare EVAX & GTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • GTI
  • Stock Information
  • Founded
  • EVAX 2008
  • GTI 2019
  • Country
  • EVAX Denmark
  • GTI Malaysia
  • Employees
  • EVAX N/A
  • GTI N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • GTI
  • Sector
  • EVAX Health Care
  • GTI
  • Exchange
  • EVAX Nasdaq
  • GTI NYSE
  • Market Cap
  • EVAX 16.3M
  • GTI 16.2M
  • IPO Year
  • EVAX 2021
  • GTI N/A
  • Fundamental
  • Price
  • EVAX $1.64
  • GTI $0.10
  • Analyst Decision
  • EVAX Strong Buy
  • GTI
  • Analyst Count
  • EVAX 2
  • GTI 0
  • Target Price
  • EVAX $10.00
  • GTI N/A
  • AVG Volume (30 Days)
  • EVAX 64.1K
  • GTI 2.1M
  • Earning Date
  • EVAX 05-27-2025
  • GTI 05-27-2025
  • Dividend Yield
  • EVAX N/A
  • GTI N/A
  • EPS Growth
  • EVAX N/A
  • GTI N/A
  • EPS
  • EVAX N/A
  • GTI N/A
  • Revenue
  • EVAX $3,344,000.00
  • GTI N/A
  • Revenue This Year
  • EVAX $102.45
  • GTI N/A
  • Revenue Next Year
  • EVAX $100.30
  • GTI N/A
  • P/E Ratio
  • EVAX N/A
  • GTI N/A
  • Revenue Growth
  • EVAX 4480.82
  • GTI N/A
  • 52 Week Low
  • EVAX $1.20
  • GTI $0.07
  • 52 Week High
  • EVAX $20.81
  • GTI $7.51
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 55.67
  • GTI 39.71
  • Support Level
  • EVAX $1.42
  • GTI $0.10
  • Resistance Level
  • EVAX $1.62
  • GTI $0.11
  • Average True Range (ATR)
  • EVAX 0.11
  • GTI 0.01
  • MACD
  • EVAX 0.03
  • GTI 0.00
  • Stochastic Oscillator
  • EVAX 62.86
  • GTI 6.32

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About GTI GRAPHJET TECHNOLOGY

Graphjet Technology is a company that owns state-of-the-art technology for the manufacture of artificial graphene and graphite, critical raw materials used in a variety of industries. The technology was developed through our collaboration with National University of Malaysia and Universiti Teknikal Malaysia Melaka. It produces artificial graphite and graphene from palm seed kernels, a waste product widely available in Malaysia and other countries that produce palm seed oil. Unlike mineral coal-based or petroleum-based graphite which is ultimately limited and must be mined and processed to produce commercial-grade graphite, our raw materials are renewable and effectively unlimited.

Share on Social Networks: